PML, promyelocytic leukemia, 5371

N. diseases: 274; N. variants: 14
Disease: Leukopenia ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0023530
Disease: Leukopenia
Leukopenia 		0.120 Biomarker disease BEFREE Secondary endpoints, including grade ≥ 3 neutropenia (frequency, 91% and 82% for MYL-1401H and reference pegfilgrastim, respectively), time to ANC nadir (mean (SD), 6.2 (0.98) and 6.3 (1.57) days), and duration of post-nadir recovery (mean (SD), 1.9 (0.85) and 1.7 (0.91) days) were comparable. 30824956 2019
CUI: C0023530
Disease: Leukopenia
Leukopenia 		0.120 GeneticVariation disease BEFREE In patients with active Crohn's disease, natalizumab therapy increases the risk for PML, and the increased risk is thought to be associated with iatrogenic leukopenia within the CNS. 28961770 2018
CUI: C0023530
Disease: Leukopenia
Leukopenia 		0.120 Biomarker disease HPO